| Fugazzola, Laura |
| Active, not recruiting | 3 | 291 | Europe, Canada, Japan, US, RoW | Selpercatinib, LY3527723, LOXO-292, Cabozantinib, Vandetanib | Loxo Oncology, Inc., Eli Lilly and Company | Medullary Thyroid Cancer | 05/23 | 02/26 | | |
| Active, not recruiting | 3 | 154 | Europe, Canada, US, RoW | Veligrotug (VRDN-001) Phase 1/2 MAD (HV and TED), VRDN-001 Phase 3 Cohort (THRIVE), VRDN-001 Placebo | Viridian Therapeutics, Inc., Viridian Therapeutics, Inc. | Thyroid Eye Disease | 07/24 | 03/25 | | |
| Recruiting | N/A | 222 | Europe | Blood and urine diagnostic evaluation | Istituto Auxologico Italiano | Endocrine Disruptor Chemicals, Thyroid Cancer | 04/23 | 07/25 | | |
NCT05765695: Radiofrequency Ablation in TIR3A Nodules With Negative Genetic Evaluation |
|
|
| Recruiting | N/A | 30 | Europe | Radiofrequency ablation performed with a 19 gauge STARmed needle. | Istituto Auxologico Italiano | Thyroid Nodule | 01/25 | 01/25 | | |
| Recruiting | N/A | 15000 | Europe | Standard treatment | University of Roma La Sapienza, Italian Thyroid Cancer Observatory (ITCO) Foundation, Catholic University of the Sacred Heart | Thyroid Neoplasms | 01/25 | 01/25 | | |
| Recruiting | N/A | 600 | Europe | Genotyping | Istituto Auxologico Italiano | Papillary Thyroid Cancer | 10/27 | 12/27 | | |
| Recruiting | N/A | 3000 | Europe | | Istituto Auxologico Italiano | Thyroid Cancer | 03/32 | 03/42 | | |
| Persani, Luca LP |
| Recruiting | 2 | 64 | Europe | Tocilizumab 20 Mg/mL Intravenous Solution, Actemra, MethylPREDNISolone Injectable Solution, Solumedrol | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Mauriziano Umberto I Hospital, Istituto Auxologico Italiano, Azienda Ospedaliera "Sant'Andrea", Azienda Ospedaliero, Universitaria Pisana | Graves Ophthalmopathy | 12/22 | 12/23 | | |
| Recruiting | N/A | 150 | Europe | NGS sequencing, serological tests | Istituto Auxologico Italiano, ASST Fatebenefratelli Sacco, Federico II University | Resistance, Thyroid Hormone | 12/24 | 04/25 | | |
VIREC, NCT05801016: Virtual Reality and Autobiographical Recall in Anorexia Nervosa: a Preliminary Study |
|
|
| Recruiting | N/A | 20 | Europe | Emerging Technologies and Training in Neurosciences | Istituto Auxologico Italiano | Anorexia Nervosa | 03/23 | 01/24 | | |
| Active, not recruiting | N/A | 220 | Europe | blood testing, thyroid US scan in case of thyroid dysfunctions | Istituto Auxologico Italiano | COVID-19 Pandemic, Endocrine System Diseases | 12/23 | 06/24 | | |
NCT06645951: Institution of an Italian Multicenter Database of Patients With Parathyroid Carcinoma or Atypical Parathyroid Adenoma |
|
|
| Not yet recruiting | N/A | 300 | Europe | | F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore | Parathyroid Gland Carcinoma, Parathyroid Gland Atypical Adenoma | 11/34 | 11/34 | | |
NCT06645899: Institution of an Italian Multicenter Database of Patients Affected by Hypoparathyroidism or Pseudohypoparathyroidism |
|
|
| Not yet recruiting | N/A | 600 | Europe | | F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore | Hypoparathyroidism, Pseudo Hypoparathyroidism | 11/34 | 11/34 | | |
| Recruiting | N/A | 15000 | Europe | Standard treatment | University of Roma La Sapienza, Italian Thyroid Cancer Observatory (ITCO) Foundation, Catholic University of the Sacred Heart | Thyroid Neoplasms | 01/25 | 01/25 | | |
NCT06790251: Institution of an Italian Multicenter Database of Patients With Multiple Endocrine Neoplasia Type 1 (MENNET1 Database) |
|
|
| Not yet recruiting | N/A | 600 | Europe | | F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore | Multiple Endocrine Neoplasia Type 1 | 05/35 | 05/35 | | |
